Select Medical released FY2024 annual earnings on February 20 After-Market (EST), actual revenue 5.187 B USD (forecast 6.812 B USD), actual EPS 1.6989 USD (forecast 2.0028 USD)

Brief Summary

Select Medical Holdings reported 2024 fiscal year revenue of $5.187 billion and EPS of $1.6989, both missing market expectations of $6.812 billion in revenue and $2.0028 in EPS.

Impact of The News

Overview

The financial briefing indicates that Select Medical Holdings underperformed relative to market expectations in both revenue and earnings per share (EPS) for the 2024 fiscal year.

Market Expectations

• Revenue: The company’s reported revenue of $5.187 billion fell short of the expected $6.812 billion.
• EPS: The reported EPS of $1.6989 also missed the anticipated $2.0028.

Comparison with Peers

• Compared to other companies like Equitrans Midstream, which managed to surpass EPS expectations with significant growth, despite lower sales benzinga_article, Select Medical Holdings failed to meet market benchmarks, indicating significant underperformance in its sector.

Business Status and Trends

• Revenue Decline: The substantial miss in revenue suggests underlying challenges in sales and possibly market demand, possibly pointing to issues in operational efficiency or competitive pressures.
• EPS Impact: The lower-than-expected EPS suggests reduced profitability, which might affect investor confidence and could lead to strategic shifts in business operations or cost management.
• Future Outlook: If the current trends persist, Select Medical Holdings might need to reassess its business strategies, focusing on improving operational efficiencies, market positioning, and cost control to align more closely with market expectations and enhance competitive standing.